Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $16.36 up 0.25% from its previous closing price of $16.32. In other words, the price has increased by $0.25 from its previous closing price. On the day, 1.76 million shares were traded. ALHC stock price reached its highest trading level at $16.48 during the session, while it also had its lowest trading level at $16.1401.
Ratios:
For a deeper understanding of Alignment Healthcare Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 2.34.
On July 31, 2025, Barclays Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $13. Stephens Upgraded its Equal-Weight to Overweight on December 03, 2024, whereas the target price for the stock was revised from $13 to $17.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 25 ’25 when Wagner Andreas P. sold 12,032 shares for $16.47 per share. The transaction valued at 198,167 led to the insider holds 192,043 shares of the business.
ANDREAS WAGNER bought 12,032 shares of ALHC for $190,587 on Aug 25 ’25. On Aug 22 ’25, another insider, Kim Hyong, who serves as the Chief Medical Officer of the company, sold 24,800 shares for $16.00 each. As a result, the insider received 396,800 and left with 447,367 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3239787520 and an Enterprise Value of 3065672960. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.97 while its Price-to-Book (P/B) ratio in mrq is 22.97. Its current Enterprise Value per Revenue stands at 0.919 whereas that against EBITDA is 389.737.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.19, which has changed by 0.667686 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $8.65. The 50-Day Moving Average of the stock is 17.56%, while the 200-Day Moving Average is calculated to be 12.76%.
Shares Statistics:
For the past three months, ALHC has traded an average of 3.36M shares per day and 2646320 over the past ten days. A total of 197.96M shares are outstanding, with a floating share count of 136.12M. Insiders hold about 31.27% of the company’s shares, while institutions hold 74.12% stake in the company. Shares short for ALHC as of 1755216000 were 12063140 with a Short Ratio of 3.59, compared to 1752537600 on 13268490. Therefore, it implies a Short% of Shares Outstanding of 12063140 and a Short% of Float of 9.379999999999999.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of Alignment Healthcare Inc (ALHC) in the stock market.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.06.
Analysts are recommending an EPS of between $0.18 and $0.11 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.32, with 4.0 analysts recommending between $0.4 and $0.26.
Revenue Estimates
A total of 10 analysts believe the company’s revenue will be $980.9M this quarter.It ranges from a high estimate of $983.6M to a low estimate of $978M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $692.43MFor the next quarter, 10 analysts are estimating revenue of $977.65M. There is a high estimate of $984.01M for the next quarter, whereas the lowest estimate is $968M.
A total of 10 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.91B, while the lowest revenue estimate was $3.89B, resulting in an average revenue estimate of $3.9B. In the same quarter a year ago, actual revenue was $2.7BBased on 10 analysts’ estimates, the company’s revenue will be $4.97B in the next fiscal year. The high estimate is $5.47B and the low estimate is $4.77B.
